Johnson & Johnson
Latest statistics and disclosures from Johnson & Johnson's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PTGX, RAPP, LEGN, CTNM, CVRX, and represent 64.38% of Johnson & Johnson's stock portfolio.
- Added to shares of these 1 stock: CLSD.
- Started 1 new stock position in CLSD.
- Reduced shares in these 2 stocks: PHGE, ALDX.
- Sold out of its position in ALDX.
- Johnson & Johnson was a net seller of stock by $-2.7M.
- Johnson & Johnson has $427M in assets under management (AUM), dropping by 6.65%.
- Central Index Key (CIK): 0000200406
Tip: Access up to 7 years of quarterly data
Positions held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 20 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 25.8 | $110M | 2.4M | 45.00 |
|
|
| Rapport Therapeutics (RAPP) | 12.0 | $51M | 2.5M | 20.48 |
|
|
| Legend Biotech Corporation Sponsored Ads (LEGN) | 9.3 | $40M | 815k | 48.73 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 8.9 | $38M | 2.0M | 19.14 |
|
|
| CVRX (CVRX) | 8.5 | $36M | 4.1M | 8.81 |
|
|
| Nanobiotix Sponsored Ads (NBTX) | 7.6 | $32M | 5.6M | 5.75 |
|
|
| Procept Biorobotics Corp (PRCT) | 6.7 | $29M | 358k | 80.12 |
|
|
| Meiragtx Holdings (MGTX) | 6.5 | $28M | 6.6M | 4.17 |
|
|
| Neumora Therapeutics (NMRA) | 5.7 | $24M | 1.8M | 13.21 |
|
|
| Xencor (XNCR) | 3.5 | $15M | 748k | 20.11 |
|
|
| Fate Therapeutics (FATE) | 2.8 | $12M | 3.4M | 3.50 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 1.1 | $4.8M | 248k | 19.37 |
|
|
| Rallybio Corp (RLYB) | 1.0 | $4.3M | 3.6M | 1.17 |
|
|
| Nano-X Imaging Ord Shs (NNOX) | 0.2 | $966k | 159k | 6.08 |
|
|
| Vor Biopharma (VOR) | 0.2 | $752k | 1.1M | 0.70 |
|
|
| D Fluidigm Corp Del (LAB) | 0.1 | $602k | 312k | 1.93 |
|
|
| Adicet Bio (ACET) | 0.1 | $525k | 365k | 1.44 |
|
|
| Chardan Healthcare Acqu- Ord (PHGE) | 0.0 | $196k | -89% | 192k | 1.02 |
|
| Clearside Biomedical (CLSD) | 0.0 | $105k | NEW | 83k | 1.27 |
|
| Senseonics Hldgs (SENS) | 0.0 | $19k | 55k | 0.35 |
|
Past Filings by Johnson & Johnson
SEC 13F filings are viewable for Johnson & Johnson going back to 2021
- Johnson & Johnson 2024 Q3 filed Nov. 13, 2024
- Johnson & Johnson 2024 Q2 filed Aug. 9, 2024
- Johnson & Johnson 2024 Q1 filed May 10, 2024
- Johnson & Johnson 2023 Q3 filed Nov. 9, 2023
- Johnson & Johnson 2023 Q2 filed Aug. 2, 2023
- Johnson & Johnson 2023 Q1 filed May 11, 2023
- Johnson & Johnson 2022 Q4 filed Feb. 9, 2023
- Johnson & Johnson 2022 Q3 filed Nov. 10, 2022
- Johnson & Johnson 2022 Q2 filed Aug. 10, 2022
- Johnson & Johnson 2022 Q1 filed May 9, 2022
- Johnson & Johnson 2021 Q4 filed Feb. 14, 2022
- Johnson & Johnson 2021 Q3 restated filed Nov. 16, 2021
- Johnson & Johnson 2021 Q3 filed Nov. 12, 2021